Developing, funding & conducting clinical trials in immune tolerance

Learn about our research

Enroll in a Clinical Trial

Autoimmune Disease
Autoimmune Disease
ITN is identifying therapies to achieve durable clinical remission of autoimmune disease
Allergy & Asthma
Allergy & Asthma
ITN is focused on achieving durable desensitization to allergen exposure
Transplantation
Transplantation
ITN's goal is to induce tolerance of transplanted organs without lifelong immunosuppression

We're advancing the clinical application of immune tolerance.

Immune Tolerance Network
STRATEGIC PLANS

REQUEST FOR PROPOSAL
Clinical trials of desensitization in solid organ transplantation

TRIALSHARE
Access raw data, analysis and clinical specimens

Featured

CONTROL-RA

CONTROL-RA will investigate how study drug, VIB4920, affects control of rheumatoid arthritis.

BEAT-MS Study

BEAT-MS will compare autologous hematopoietic stem cell transplant (AHSCT) to the most effective standard treatment in MS.

REVEAL Study

The REVEAL Study will determine whether an experimental therapy can repigment the skin in vitiligo.

The Immune Tolerance Network is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The ITN is focused on the development of therapeutic approaches for asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation that lead to immune tolerance.  More

 

Explore our clinical trials:

Allergy & Asthma  |  Autoimmune Disease  |  Transplantation  |  Type 1 Diabetes  |  All Clinical Trials

News

LEAP Participant Follow-up Study Publication
REVEAL Study Completes Enrollment
RESTARRT Primary Paper Published
Remembering Jean-Francois Bach